An in vitro system to study drug sensitivity of Mycobacterium leprae using infected human tissue by Vithala, Lakshmi et al.
 Biosci., Vol. 5, Number 3, September 1983, pp. 235–241   © Printed in India. 
 
 
 
 
An in vitro system to study drug sensitivity of Mycobacterium
leprae using infected human tissue
 
LAKSHMI VITHALA, SWATI TALATI and P. R. MAHADEVAN
 
The Foundation for Medical Research, 84-A, R.G. Thadani Marg, Worli,
Bombay 400 018 
 
MS received 25 September 1982; revised 20 July 1983
 
Abstract. A reliable screening technique for assessing the sensitivity of Mycobacte- 
rium leprae to drugs has been developed. The method is based on the susceptibility or 
otherwise of M. leprae–infected tissues from lepromatous leprosy patients to the action 
of diaminodiphenyl sulphone (dapsone) or rifampicin on the incorporation of [14C]- 
acetate into lipids. The extent of inhibition or lack of inhibition correlated very well with 
the drug sensitivity or resistance of the bacteria isolated from the patients to the above 
drugs. A similar trend was observed when the incorporation into individual fractions of 
neutral lipids was measured. There was no incorporation by heat-killed tissues. This 
method correlates well with the 3,4-dihydroxyphenylalanine uptake studies.
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Introduction 
 
Successful development of antimicrobial compounds is the end result of a rational 
screening programme against known microbes by simple and quick in vitro sys-
tems, followed by preliminary toxicological studies on the compounds which
show promise. All microbes that can be cultivated can be subjected to these
screening tests. Mycobacterium leprae which has resisted in vitro cultivation despite
efforts by several workers, cannot be tested by these methods. The mouse foot pad
model of Shepard (1960) and Rees (1964) is the most widely used method, but is
limited by the long time period of 6 to 9 months required for assay. 
There are currently two in vitro tests in use, one developed in our laboratory by
Ambrose et al. (1974, 1978) using uptake of labelled L-3,4-dihydroxy (ring-2,5,6-
3H) phenylalanine (DOPA) by partially purified M. leprae and the other using in-
corporation of [3H]-thymidine by M. leprae inside the macrophages (Drutz and
Cline, 1972; Talwar et al., 1974; Prasad and Nath, 1981; Nath et al., 1982).
Initial studies in our laboratory showed that Mycobacterium lepraemurium infected 
liver and spleen tissue from mice, when incubated with [14C]-acetate for one week
in Minimal Eagle’s medium containing serum, incorporated the precursor into the
bacterial-bound lipid portion, identified as mycolic acids. The incorporation 
decreased in the presence of drugs like isoniazid, rifampicin and streptomycin.
These observations formed the basis to study the incorporation of [14C]-acetate
into the lipids of M. leprae in human biopsy material, freshly obtained from
patients, in the presence and absence of known antileprosy drugs namely
 
 
Abbreviations used: DOPA, L-3, 4-Dihydroxyphenylalanine; dapsone, diaminodiphenyl sulphone.
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diaminodiphenyl sulphone (dapsone) and rifampicin. In this paper we describe
the effect of dapsone and rifampicin on the incorporation of [14C]-acetate into 
experiments to study the synthesis of the various lipid components by M. leprae 
contained in biopsy tissue obtained from leprosy patients and the effect of dapsone 
and rifampicin. 
 
Materials and methods
 
Uptake of [14C]-acetate 
 
Human skin biopsis from M. leprae infected patients were obtained from the 
Acworth Leprosy Hospital, Bombay. The biopsies were collected from lepromat- 
ous leprosy patients from the ear lobe or young skin lesions, under asceptic condi- 
tions. It was processed within 3 h after collection. The tissue was washed with 
saline followed by a wash with Minimal Essential Medium containing penicillin 
(50 units/ml). It was chopped into small pieces and each piece was transferred to 
a 10 ml flask containing Eagle’s Minimal Essential Medium, containing additional 
20% AB type human serum. 
Two controls were used, one untreated tissue and the other heat-killed tissue.
The drug-treated tissues included dapsone (10 µg/ml) and rifampicin (5 µg/ml).
The reaction mixture contained 0.5 µCi/ml of l,2-[14C]-acetate (specific activity
58.6 mCi/mmol; obtained from Isotope Division, Bhabha Atomic Research
Centre, Bombay). Penicillin (100 units/ml) and Mycostatin (50 units/ml) were 
added to the medium as antibacterial and antifungal agents. The cultures were 
incubated at 34±1°C and the flasks were kept in a dessicator with 100% humidity
and maintained for 11 days, the medium containing [14C]-acetate was changed
every 3 days. 
On completion of this period, the tissue was suspended in about 3 ml of saline 
and autoclaved at 15 lbs pressure for 30 min. The tissue was homogenized in a 
power driven Potter-Elvehjem type homogenizer fitted with a teflon pestle for 2
min and the homogenate was centrifuged at 182 g in a Sorvall refrigerated centri-
fuge to remove the tissue debris. The supernatant, containing the bacilli was cen-
trifuged at 11,700 g for 15–20 min. The sediment, containing bacilli was washed 
with saline and after recentrifugation, suspended in an appropriate volume of 
saline. Bacillary lipids were extracted by the method of Folch et al. (1957). 
Radioactivity in each preparation at various stages was determined using a 
Kontron MR 300 Liquid Scintillation spectrometer after mixing the sample with 
Bray’s scintillation fluid (Bray, 1960). 
The extracted lipids were separated by thin layer chromatography using
Silica Gel G (BDH) (0.25 mn thickness) and a solvent system containing
hexane: ether: glacial acetic acid (80:20:1 v/v). The separated neutral lipids
were visualised with iodine and identified by comparison with standards. The
radioactivity associated with the various lipids was measured by scrapping the gel 
corresponding, to the standard spots from the plate and suspending in Bray’s scin- 
tillation fluid and measuring the radioactivity. Normal skin biopsies obtained from 
non-leprosy individuals was also processed in a similar manner. All reagents used 
were of the analytical grade. 
 
Uptake of [3H]-DOPA 
 
Eight biopsies were processed for drug trials by the method described above and
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by the method developed earlier in our laboratory using L-3,4-dihydroxy (ring-
2,5,6-3H) phenylalanine (specific activity 1 Ci/mmol; obtained from Amersham,
England) uptake as an index of bacterial viability and drug sensitivity of M. leprae
(Ambrose et al., 1974, 1978). 
 
Results 
 
Effect of drug on [14C]-acetate incorporation in normal tissues
 
Before one could study the uptake of [14C]-acetate in lepromatous tissue one 
should know the type of incorporation of the precursor into lipids of normal skin. 
The uptake of [14C]-acetate by the normal skin tissue and its incorporation into 
lipids in the presence and absence of dapsone is shown in table 1. The relative 
incorporation in the lipids under both the experimental condtions was similar sug- 
gesting that dapsone had no significant effect on the lipid synthesis of cells in nor-
mal skin tissue. 
 
Table 1. Relative incorporation of [14C]-acetate into lipids of normal skin in
presence and absence of dapsone.
 
 
a Results expressed as percentage of radioactivity incorporated into lipids
in relation to total uptake of the precursor. 
b  P<0.05. 
 
Bacterial lipid synthesis in leprosy tissues 
 
Lepromatous tissue obtained from four different patients were studied for the
incorporation of [14C]-acetate in the tissue as well as in the bacteria present in the 
tissue (table 2). It is evident that both the tissue and bacteria incorporate [14C]- 
acetate into lipids. Such incorporation was drastically reduced in the heat killed 
tissue. If the incorporation in total lipids is a relevant metabolic event, then one 
should be able to identify the various lipid components with the [14C]-label. In 
table 3 the radioactivity associated with the various lipid components separated by
thin layer chromatography are shown. It is clear from this, while incorporation is 
distributed in several lipid components, the pattern of incorporation is different in 
normal and infected skin. In infected skin there was much less incorporation into
cholesterol as well as diglycerides. An unidentified spot of radioactivity was seen in
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Table 2. Incorporation of [14C]-acetate into total lipids of M. leprae and its host 
tissue. 
 
a Bacteriological Index is calculated as nos of bacilli/field
 
1-10/100/fields  1+ 
1-10/10 fields 2+ 
1-10/1 field 3+ 
1-100/field 4+
1-1000/field 5+ 
 1000/field 
 clumps 6+ 
 
b Morphological Index is calculated as percentage of stained bacilli as solid forms: an indication
of viable proportion of the total bacilli. 
 
Table 3. Radioactive distribution of [14C]-acetate in the neutral lipids of normal and 
M. leprae infected skin. 
 
infected skin, which was not seen in normal skin. It will be shown later that this
spot is probably derived from bacteria.
 
Effect of drugs on lipid synthesis by bacteria 
 
Lepromatous tissue containing M. leprae was exposed to the precursor in presence
and absence of the drug dapsone using eleven different infected tissues (table 4)
and with rifampicin for five infected tissues (table 5). It was observed that the total
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Table 4. Effect of dapsone on the incorporation of [14 C]-acetate into lipids of M. leprae. 
 
a Ratio of incorporation into bacteria to that into the tissue (%). 
b Bacterological Index 
 Morphological Index 
c P<0.05. 
d P<0.001. 
 
 
Table 5. Rifampicin effect on the incorporation of [14C]-acetate into lipids of M. leprae. 
 
a Ratio of incorporation into bacteria to that into the tissue (%). 
b Bacterological Index 
 Morphological Index 
c P < 0 . 0 5  
d P<0.001. 
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synthesis of lipids in the bacteria in the presence of dapsone or rifampicin was 
drastically reduced, in all these cases. The difference in the amount of incorpora- 
tion between the control and drug treated tissue was statistically significant. If one 
were to look at lipid components form the bacteria separated from these tissues 
under the above conditions, it would be clear that the total reduction in lipids was 
also reflected in the reduced level of incorporation in the presence of dapsone. Vir- 
tually most components showed lower level of incorporation in the presence of
dapsone and rifampicin. 
However, if the lepromatous tissues are derived from patients suspected to har- 
bour resistant bacteria to the drugs under administration or have been proved to 
have relapse, then the total incorporation into lipids of Μ. leprae is not reduced in 
the presence of the drug. The data in tables 4 and 5 provide the total incorporation 
of the label into lipids of the bacteria obtained from suspected drug resistant
patients for dapsone and rifampicin respectively. It is clear that the drug has no 
effect on the corporation into lipids of bacteria indicative of the resistance. The
levels of synthesis in the control and drug treated, are not statistically significant. 
The control value from the 7 and the 11 samples in table 4 were comparable, but 
drug treated samples markedly differed showing sensitivity of the bacteria for dap- 
sone in the 11 cases and resistance of the bacteria to the drug in the 7 cases studied. 
The level of incorporation of the precursor into lipid components was higher 
whenever drug resistant strains were tested as compared to incorporation in the 
absence of this drug. We have no explanation for this observation at present. But a 
clearer idea could be obtained when the drug resistant bacteria are studied in a
cell-free system. 
 
Correlation of DOPA method and acetate method 
 
M. leprae from the tissues of the 8 patients were also tested for their sensitivity/
resistance to the drugs rifampicin and dapsone by another method developed in 
our laboratory (Ambrose et al., 1974; 1978) using labelled DOPA. Uptake of
DOPA and its conversion to other metabolities is one of the characteristic feature of
live M. leprae (Prabhakaran et al., 1968; Prabhakaran, 1973). We observed that the
drug reduced drastically the uptake of DOPA in the sensitive strains, while it had
very little or no effect on DOPA uptake by the resistant strains. These results cor-
roborate well with the drug sensitivity/resistance in the bacteria when the uptake
of labelled acetate is measured in the presence of the drugs. 
Bacteria from, one of the tissues (FMR 299) were tested for sensitivity to dap-
sone by the mouse footpad technique (Shepard, 1960). Harvests were carried out
after 6, 8 and 10 months of growth in the mice. The results indicate that the bacteria
from the patient were sensitive to dapsone as was indicated by the [14C]-acetate
uptake system. 
 
Discussion 
 
Experiments carried out with M. lepraemurium-infected liver and spleen tissue
showed that acetate could be incorporated into mycolic acids but this was not the
case with M. leprae obtained from skin of infected human subjects. Labeling in my-
colic acids could not be obtained in the human bacilli probably for two reasons: a
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slow metabolic turnover of this lipid or the pathway for the biosynthesis of these
acids involves a different precursor.
But we found that there was a significant incorporation in the chloroform-
methanol extractable lipids in tissues containing M. leprae as well in the compo-
nents separated after thin layer chromatography. Furthermore, the observation
that dapsone and rifampicin decreased the percentage of label incorporated in the
lipid portion of tissues containing M. leprae from patients resistant to the drug, 
while in resistant strains, the acetate incorporation into lipids was not inhibited
correlated with the clinical status of the patient. 
The absence of a significant difference in the incorporation of label in the con-
trol and drug treated normal skin indicated that the drug was probably effecting 
bacilli and not the metabolism of the tissue components. Biopsies which were 
examined for [14C]-acetate incorporation into lipids, were also used to study [3H]- 
DOPA uptake method to test drug sensitivity. The correlation between these two
methods was quite good. Bacilli from one of the patients were inoculated into the
mouse foot pad and the sensitivity to dapsone was shown even in the mouse.
Screening for drug sensitivity using [14C]-acetate is rapid and results can be
obtained within a period of 15 days. It is more informative than the method using
[3H]-DOPA uptake because acetate can be traced in the various lipid fractions,
especially triglycerides and fatty acids. There is no ambiguity in the results and
reproducibility appears to be good. The level of radioactive incorporation is fairly
good unlike the incorporation of precursors into DNA (Nath et al., 1982). Bacilli
with a Morphological Index of even 1% shows an uptake of the precursor. 
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